Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-02-11

FDA Approved: EYE ITCH RELIEF — Supplemental Application (Target Corporation)

View source ↗

Summary

The FDA approved a supplemental application for Eye Itch Relief (ketotifen fumarate) by Target Corporation. The product is an ophthalmic treatment intended to r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eye Itch Relief (Ketotifen fumarate)

Snippet

SUPPL AP for EYE ITCH RELIEF (KETOTIFEN FUMARATE)